The Role of High Density Surface ECG in the Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)

Brief Title

The Role of High Density Surface ECG in the Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)

Official Title

The Role of High Density Surface Cardiac Electrographic Mapping in the Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy :A Pilot Study

Brief Summary

      The diagnosis of Arrhythmogenic right ventricular cardiomyopathy can be difficult. The 80
      lead ECG may increase the specificity and sensitivity in diagnosing this potentially life
      threatening inherited cardiac condition. This pilot would form the basis of a much larger
      clinical trial to test the utility of this novel diagnostic tool.
    



Study Type

Interventional


Primary Outcome

QRS wave dispersion in an ECG


Condition

Arrhythmogenic Right Ventricular Cardiomyopathy

Intervention

80 lead ECG

Study Arms / Comparison Groups

 Patient
Description:  Patients with previously confirmed Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)

Publications

* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.

Recruitment Information


Recruitment Status

Device

Estimated Enrollment

20

Start Date

August 2012

Completion Date

October 2012

Primary Completion Date

October 2012

Eligibility Criteria

        Inclusion Criteria:

          -  Patients with a confirmed diagnosis of arrhythmogenic right ventricular cardiomyopathy
             who are being followed up in the cardiology clinic

        Exclusion Criteria:

          -  Inability to consent

          -  Pacing dependent patients

          -  Other concomitant cardiag disease e.g. coronary artery disease

          -  Atrial fibrillation
      

Gender

All

Ages

18 Years - 80 Years

Accepts Healthy Volunteers

Accepts Healthy Volunteers

Contacts

, , 



Administrative Informations


NCT ID

NCT02291393

Organization ID

CD12/10936

Secondary IDs

12/YH/0346

Responsible Party

Sponsor

Study Sponsor

The Leeds Teaching Hospitals NHS Trust


Study Sponsor

, , 


Verification Date

May 2015